In the wake of COVID-19 pandemic many life sciences organizations are reviewing their clinical operations strategy as areas of weakness in their processes were even more apparent during this pandemic.
Hear how two leading life sciences organizations are transforming their clinical operations, specifically by using process and data management to orchestrate informed decision-making throughout their operations of clinical studies and the early stages
of protocol design and development. We’ll discuss how hyperautomation can replace manual processes throughout various clinical operations workflows associated with the following processes:
- Study Design & Execution Life-cycle (SDEL)
- Site Identification & Selection
- Study Start Up Management
- Clinician Onboarding & Credentialing Management
- Centralized Site & Study Monitoring
- Global Contracting Agreements RFPs & Tender Management
Plus, have an open discussion on challenges and innovations of Hyperautomation in Clinical Operations in order to execute clinical studies more rapidly and efficiently.
This webinar will benefit professionals involved in:
- Protocol Design & Execution
- Site Identification & Selection
- Study Start-Up Management
- Clinician Onboarding & Credentialing Management
- Centralized Site & Study Monitoring
Eddie Dukes, MS
Tech Product Owner, GSK
Eddie Dukes is a tech innovation enthusiast and visionary. He has been with GSK for over 6 years in various tech-related roles and is currently a Product Owner within the R&D Tech Clinical Portfolio and Solutions organization. Eddie provides leadership to cross-functional teams from a technology perspective and is experienced in designing and implementing technology solutions to maximize operational efficiency and enable data-driven decision making. Eddie is a part-time postgraduate student with University College London, studying towards an MSc in Entrepreneurship with a vision to build high-impact technology ventures in the clinical sector.
Clarissa Watts
Clinical Development Director, GSK
Clarissa Watts has more than 30 years’ experience in the Pharmaceutical Industry in roles spanning from Exploratory Research to late phase Clinical Trials. She has a passion for driving improvements in processes to enable everyone to focus on the value-added work. Her current role involves supporting the Clinical Trials operations teams to optimize study plans based on data driven decision making and robust challenge supported by a connected and intuitive IT landscape.
Donald (Don) Thampy
Director of Operations, Merck
Donald has worked in Operations in various industries of which the last 15 years has been in Pharma, in both Sponsor and Partner ecosystems. He loves to work with people, living in this VUCA environment, by collaborating and enabling new ways of thinking, working and living. Focus for Donald is to relentlessly add value, to the organization, functions and individuals. As Director of Operations in the Global Clinical Data Integration (GCDI) function at Merck, Donald and his team are responsible for assisting with the success of the evolving operating model of GCDI and make the sub-functions in GCDI look good. Prior to Merck Donald’s prior roles included account management, service delivery management, transition management, sales and business development strategy. Donald is a postgraduate in business administration major in finance.
Bryan Kropp
Executive Director, Clinical Data Management, Merck
Rob Saiter
Managing Director, Accenture
Mr. Saiter is a Managing Director in the Accenture’s Life Sciences R&D practice. He leads Accenture’s Veeva Vault practice and is also responsible for our R&D technology work in North America. He has 22 years of experience developing and delivering business and technology transformation programs within Pharmaceutical R&D organizations.
Mr. Saiter’s work has focused extensively on clinical development operations, clinical data management, statistical programming, clinical data warehousing, clinical supplies, mHealth and site and investigator collaboration.
Evi Cohen
Vice President, Global Life Sciences and Healthcare, Appian
Evi is an experienced pharmaceutical executive with extensive background in developing global business portfolios with emphasis on new products, technologies, and IP. He is a skilled innovation management professional with experience managing global business process transformations and cross-functional teams. As Vice President, Global Life Sciences and Healthcare at Appian, Evi is responsible for client success and continued steady growth in license revenues across all pharmaceutical and healthcare clients.
Appian helps organizations build apps and workflows rapidly, with a low-code automation platform. Combining people, technologies, and data in a single workflow, Appian can help companies maximize their resources and improve business results. Many of the world’s largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance. For more information, visit www.appian.com.